Welcome to YLOAN.COM
yloan.com » Marketing » Tuberculosis - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Tuberculosis - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market

Tuberculosis - Drug Pipeline Analysis and Market Forecasts to 2016


Summary

Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global Tuberculosis (TB) drugs market. The report identifies the key trends shaping and driving the global TB market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to significantly alter the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global TB sector. The global TB drugs market was worth $99m in 2009. The market is expected to decline by 2.8% during the next seven years. The TB drugs market has been well served by antimycobacterial agents and antibiotics since the 1960s. The cure rates have improved with the conventional DOTs (Directly Observed Therapy). Multi-Drug Resistant Tuberculosis (MDR-TB) has been a consequence of patient non-compliance and the long duration of therapy. Companies seem to be actively developing products for the prophylaxis and cure of TB that have lesser treatment durations. The two not-for-profit organizations, TB Alliance and the Aeras Global TB Vaccine Foundation, have partnered with pharmaceutical players in order to address the burden of TB in developed and developing nations. With the success of the ongoing clinical studies, the market is expected to witness a breakthrough in TB control and treatment. The vaccines primary focus would be to inhibit the infection at the first place. The global TB drugs market is heading towards a phase of decline as no launches are expected till 2016.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts.


Scope

The scope of the report includes:

- Annualized global Tuberculosis drugs market revenue data from 2001 to 2009, forecast for seven years to 2016.

- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing a split across the different phases of development by mechanism of action and emerging trends. The key classes of mechanism of action of drugs include ATP synthase inhibitors, protein synthesis inhibitors, cell wall synthesis inhibitors, DNA gyrase inhibitors, FAS synthase inhibitors, translocase-1 inhibitors and others. The vaccine candidates have been segmented as recombinant live vaccines, recombinant protein vaccines and viral vectored vaccines.

- Analysis of the current and future market competition in the global Tuberculosis drugs market. The key market players covered are isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin, rifabutin and capreomycin.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessments, market characterization, the unmet needs and the implications for the future market associated with TB.

For more information, please visit:

http://www.aarkstore.com/reports/Tuberculosis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-42027.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com


Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise
Hepatitis B - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market Acne - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market Research Dysmenorrhea - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market Res Tw Organisatie Awakens The World To The Wonders Of Direct Marketing How to Make More Money with Affiliate Marketing: 3 Important Tips Saving Your Sexless Marriage Scam or Any Good? How To Cure Sexless Marriages How you can profit from printed items Top 5 Tips For Effective Email Marketing -purchase articles Using Promotional Gifts To Market Your Company Use Email Marketing wisely; Stand out from Junk Mail -articles buy How to Determine Whether to buy into the Property Market How to make money with affiliate marketing - affiliate marketing proven strategies Viral Marketing At Its Best -articles for sale
print
www.yloan.com guest:  register | login | search IP(216.73.216.142) California / Anaheim Processed in 0.017948 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 44 , 3828, 66,
Tuberculosis - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market Anaheim